|
KMID : 1001020120100030124
|
|
Korean Journal of Urological Oncology
2012 Volume.10 No. 3 p.124 ~ p.129
|
|
|
New Drugs for Castration-resistant Prostate Cancer
|
|
Choi Hoon
Park Jae-Young
Park Hong-Seok
|
|
|
Abstract
|
|
|
|
Most men with advanced prostate cancer respond to various types of androgen ablation but progress to castration-resistant prostate cancer (CRPC). New therapeutic agents have been have been bsased on our knowledge of prostate cancer cell biology Recent studies have revealed the efficacy of various new treatments. These have been in diverse areas of therapeutics research, including new drugs for antiandrogenic effect, cytotoxic chemotherapy, immunotherapy and targeted biological therapy in new ways of approaching hormone refractory disease. We describe some of the valuable updates of clinical developments in the field of new therapies for CRPC.
|
|
|
KEYWORD
|
|
|
Castration-resistant prostate cancer, Chemotherapy, Immunotherapy, Targeted therapy
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|